Geltor

The burgeoning climate-focused portfolio from early-stage investor SOSV Investments has managed to raise nearly $2 billion in follow-on financing since the startup companies graduated from the investment firm’s various accelerator…

SOSV’s burgeoning climate portfolio is worth nearly $6 billion as planetary health bets pay off

Late last year, Solugen, a startup using synthetic biology to take hydrocarbons out of the chemicals industry, decided against pursuing a new round of funding that would have valued the…

Forsaking funding at a $1 billion valuation, Solugen preps a new green chemical product and a big 2021

Featured Article

Synthetic biology startups are giving investors an appetite

There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies. Perhaps the most public (and tastiest) example of the promise biomanufacturing holds is Impossible Foods. The meat replacement company whose ground plants (and bioengineered additives) taste like ground beef just raised another…

Synthetic biology startups are giving investors an appetite

The manufacturer of a vegan collagen, Geltor, has raised a new round of financing — $90 million, according to people familiar with the company. It’s another sign of the newfound…

Investments in bioproducts surge as Geltor nabs new money

The age of alternative meats is upon us.  Beyond Meat is a $5 billion public company selling burgers in Canadian McDonald’s and American Carl’s Jr., breakfast sausages in Dunkin, and…

What’s beyond Beyond Meat and Impossible Foods in the future of food?

After inking what sources said was a nine-figure deal with the world’s leading supplier of collagen proteins, Gelita, the cell-based collagen maker Geltor is in the market for at least…

After signing a big food additive deal, cell-based protein company Geltor is looking for at least $50M